Search
Filter by content type
Filter by content year
Filter by category
BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022
March 16, 2022 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech to Report Full Year Financial Results for 2020 and Provide Corporate Update on the Fourth Quarter on March 30, 2021
March 23, 2021 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech to report full year financial results for 2019 and provide corporate update on the fourth quarter on March 31, 2020
March 23, 2020 - … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma and Pfizer. For more information, please visit … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma and Pfizer. For more information, please visit … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma and Pfizer. For more information, please visit …
BioNTech to Report First Quarter 2020 Financial Results and Operational Update on May 12, 2020
May 5, 2020 - … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma and Pfizer. For more information, please visit … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma and Pfizer. For more information, please visit … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma and Pfizer. For more information, please visit …
BioNTech Announces First Quarter 2020 Financial Results and Corporate Progress
May 12, 2020 - … upfront payments due in 2Q 2020 from Pfizer and Fosun Pharma Conference call and webcast scheduled for May … Pfizer (worldwide collaboration outside of China) and Fosun Pharma (China). BioNTech’s goal is to make a vaccine … our BNT162 program in 2020 will be funded via Pfizer and Fosun Pharma cost sharing, equity investments and upfront …
BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023
October 23, 2023 - … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, … global pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update
August 9, 2021 - … have been allocated between BioNTech, Pfizer and Fosun Pharma based on marketing and distribution rights. … profit is based on COVID-19 vaccine sales in Pfizer’s and Fosun Pharma’s territories and represents a net figure. In … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit …
BioNTech Announces Third Quarter 2020 Financial Results and Corporate Progress
November 10, 2020 - … in healthy adults ages 20 to 85. In August, BioNTech and Fosun initiated a Phase 1 study to evaluate safety and … our new collaboration agreements signed with Pfizer and Fosun Pharma as part of the Company’s BNT162 vaccine program … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech veröffentlicht Ergebnisse des ersten Quartals 2020 und Informationen zur Geschäftsentwicklung
May 12, 2020 - … ohne kapitalverwässernden Effekt von Pfizer und Fosun Pharma im zweiten Quartal Telefonkonferenz und Webcast … mit Pfizer (weltweite Kollaboration außerhalb Chinas) und Fosun Pharma (China) zusammengestellt. BioNTechs Ziel ist es, … Jahr 2020 wird über die Kostenbeteiligung von Pfizer und Fosun Pharma, Kapitalbeteiligungen und Vorauszahlungen …
BioNTech veröffentlicht am 8. August 2022 Ergebnisse des zweiten Quartals sowie Informationen zum operativen Fortschritt
July 25, 2022 - … (ein Unternehmen der Roche Gruppe), Regeneron, Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … (ein Unternehmen der Roche Gruppe), Regeneron, Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … (ein Unternehmen der Roche Gruppe), Regeneron, Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie …